Epigenetics and Gene Regulation in Eukaryotes

Key differences between eukaryotes and prokaryotes

Regulation of gene expression in eukaryotes is significantly more complex, largely due to their multicellularity. The main difference in genome organization is that eukaryotes typically lack operons. Each gene represents an independent unit of transcription. The synthesized messenger RNA is monocistronic, meaning it carries information for the structure of only one protein.

Furthermore, in eukaryotes, genes are isolated from the cytoplasm by the nuclear envelope. This creates a need for complex signaling pathways. For an external stimulus to affect DNA activity, the signal must travel a long route: from the environment to the cell surface, then through the cytoplasm and the nuclear pore directly to the chromosomes. Within the genetic apparatus itself, there are unique regulatory elements absent in bacteria — these are enhancers (transcriptional upregulators) and silencers (transcriptional downregulators).

Levels of gene activity control

Gene activity is strictly controlled at several stages:

1. Regulation of DNA compaction level. Chromatin can exist in two states: accessible euchromatin and densely coiled heterochromatin, which is inaccessible to enzymes. The transition between these states is ensured by enzymatic histone modification and DNA methylation. These very processes are studied by epigenetics.
2. Primary control of transcription initiation. Here, DNA-protein interactions play a key role. Specific transcription factors (positive and negative regulatory proteins) possessing special binding domains attach to regulatory regions of DNA, stimulating or inhibiting information reading.
3. Regulation of mRNA formation (processing). Alternative splicing serves as a crucial mechanism for transforming the primary transcript into mature mRNA. It allows the cell to assemble different mRNA variants (and consequently, different proteins) based on a single initial gene.

The role of epigenetics in organism development

Epigenetic mechanisms are the key to understanding how a complex multicellular organism develops from a single genetically identical zygote. In the early stages of embryonic development, all cells are totipotent, meaning they have the potential to become any cell type in the organism. As development proceeds, they receive various chemical and hormonal signals that guide them along a specific epigenetic "route".

During differentiation, cells acquire narrow specialization (becoming neurons, cardiomyocytes, and so on). This occurs exclusively due to the activation of different sets of genes in different cell types. In an already differentiated cell, only those DNA regions necessary to perform its specific functions are expressed. The rest are suppressed through the main epigenetic mechanisms: DNA nucleotide methylation and histone deacetylation.

Clinical significance of epigenetic disorders

Failures in epigenetic regulation lead to the development of severe pathologies:

• ICF syndrome (immunodeficiency, centromeric region instability, and facial anomalies). It arises from a mutation in the DNMT3B gene. This gene encodes DNA methyltransferase, and its defect grossly disrupts the methylation process.
• Rett syndrome. A neuropsychiatric disorder occurring almost exclusively in girls. It is associated with a mutation in the MeCP2 gene on the X chromosome. Due to a defect in the binding protein, the maintenance of normal heterochromatin state is disrupted.
• Imprinting disorders. The manifestation of the disease depends on which parent the mutated chromosome was inherited from. Changes in the paternal chromosome lead to Prader-Willi syndrome (obesity, strabismus, muscular hypotonia, developmental delay). Conversely, if changes affect the same genes on the maternal chromosome, Angelman syndrome occurs (more pronounced mental retardation, sleep disorders, chaotic movements).

RNA editing: synthesis of apolipoprotein B

An interesting example of forming different proteins from a single gene is the synthesis of apolipoprotein B. There are two forms of it in the organism. The hepatic form is a large protein with a mass of 512 kDa (4536 amino acids), synthesized in the liver to transport lipids in the blood. The intestinal form performs a related function, but is significantly shorter (250 kDa, 2152 amino acids).

The shortening mechanism is as follows. The enzyme intestinal deaminase acts on the mature mRNA, converting the cytosine (C) nitrogenous base into uracil (U) at codon 2152. As a result, the CAA codon (encoding glutamine) is converted into the UAA stop codon. Premature translation termination occurs, yielding a shortened protein with a different function.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Structure and classification of DNA-binding domains in transcription factors
• Epigenetic modification enzymes: methyltransferases and deacetylases
• Mechanisms of alternative splicing and spliceosomes
• Detailed pathogenesis of ICF syndrome and the molecular role of the DNMT3B gene
• Genomic imprinting: molecular bases of selective allele inactivation

Other topics in "Molecular Genetics"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.